FANCF silencing-induced dysfunction of the FA/BRCA pathway increases sensitivity of human breast cancer cell line to MX, possibly by activating the JNK, p38 MAPK signaling pathway, subsequently increasing p53 activity, activating mitochondrial apoptosis pathway, and decreasing BCRP expression. Here, FANCA is linked to breast cancer.